Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)

ClinicalTrials.gov ID: NCT00430612

Public ClinicalTrials.gov record NCT00430612. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 11:12 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the PACE-MI (OBTAIN) registry is: * Analyze beta-blocker dose response effect on outcome over two years * Explore gender and minority differences in beta-blocker utilization and outcomes. In patients with Myocardial Infarction (MI) discharged from the hospital, beta-blocker dose will be predictive of survival. Exploratory analyses: Gender and racial effects-gender and race are, similarly, hypothesized to be predictive of post-MI survival. The existence of interactions between gender and beta-blocker effect as well as race and beta-blocker effect will also be evaluated.

Study identification

NCT ID
NCT00430612
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Northwestern University
Other
Enrollment
7,057 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2009 (Type not available)
Primary completion
Dec 2013 (Actual)
Completion
Oct 2015 (Actual)
Last update posted
Apr 24, 2023

2009 – 2015

United States locations

U.S. sites
22
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Little Rock Cardiology Clinic Little Rock Arkansas 72211 —
MemorialCare Heart and Vascular Institute - Long Beach Memorial Medical Center Long Beach California 90806 —
West Los Angeles VA Medical Center Los Angeles California 90073 —
Bridgeport Hospital Bridgeport Connecticut 06610 —
Baptist Cardiac and Vascular Institute Miami Florida 33176 —
Orlando Regional Medical Center Orlando Florida 32806 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
Clarian Health/Methodist Research Institute Indianapolis Indiana 46202 —
Henry Ford Hospital Detroit Michigan 48202 —
Park Nicollet Saint Louis Park Minnesota 55426 —
Winthrop University Hospital Bethpage New York 11714 —
Maimonides Medical Center Brooklyn New York 11219 —
Strong Memorial Hospital (University of Rochester School of Medicine) Rochester New York 14642 —
OhioHealth Research Institute Columbus Ohio 43214 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Rhode Island Hospital Providence Rhode Island 02903 —
Baptist Memorial Hospital Memphis Tennessee 38120 —
Amarillo Heart Clinic Research Institute, Inc. Amarillo Texas 79106 —
Austin Heart PLLC Austin Texas 78756 —
Providence Health Center Waco Texas 76712 —
Fletcher Allen Health Care Burlington Vermont 05401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00430612, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2023 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00430612 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →